Cencora, Inc. (COR) Enterprise Value (EV): $59.74B
The enterprise value (EV) for Cencora, Inc. (COR) is $59.74B as of Saturday, June 13, 2026.
COR Enterprise Value (EV) Metrics
ENTERPRISE VALUE (EV)
$59.74B
COR Competitors' Enterprise Value (EV)
| NAME | MARKET CAP | ENTERPRISE VALUE (EV) |
|---|---|---|
| Cencora, Inc. (COR) | $54.80B | $59.74B |
| Becton, Dickinson and Company (BDX) | $52.98B | $60.50B |
| Regeneron Pharmaceuticals, Inc. (REGN) | $63.06B | $80.33B |
| Humana Inc. (HUM) | $45.53B | $39.59B |
| IDEXX Laboratories, Inc. (IDXX) | $44.24B | $55.08B |
| Agilent Technologies, Inc. (A) | $36.67B | $42.98B |
| Zoetis Inc. (ZTS) | $33.36B | $62.97B |
| Centene Corporation (CNC) | $32.19B | $21.10B |
| Medline Inc. (MDLN) | $30.96B | $44.73B |
| Cigna Corporation (CI) | $78.83B | $96.98B |
Enterprise Value Calculation
Market Cap
$54.80B
Total Debt
$9.33B
Cash
$4.39B
Enterprise Value
$59.74B
EV-Based Valuation Multiples
Why use EV instead of Market Cap?
- EV accounts for debt - an acquirer must pay or assume it
- EV deducts cash - the acquirer effectively receives it
- EV enables fair comparison of companies with different capital structures
- EV-based ratios (EV/EBITDA, EV/Sales) are capital structure neutral
Cencora, Inc. Enterprise Value (EV) Formula & Definition
Enterprise Value represents the total value of a company as if you were to acquire it completely - paying for equity while assuming debt and receiving cash.
Expanded definitions: Investopedia, Wikipedia, Corporate Finance Institute
Cencora, Inc. Enterprise Value (EV) FAQ
- What is the enterprise value (EV) for Cencora, Inc. (COR)?
- The enterprise value (EV) for COR stock is $59.74B.
Related Metrics
About Cencora, Inc.
Cencora, Inc. functions as a global leader in the sourcing and distribution of pharmaceutical products, with operations spanning both the United States and international markets. Within its U.S. Healthcare Solutions segment, the company supplies a broad spectrum of pharmaceutical items, including generic and injectable medications, over-the-counter health products, and home healthcare equipment. Its extensive client network includes acute care hospitals, health systems, a variety of retail and mail-order pharmacies (independent, chain, long-term care), medical clinics, and other healthcare providers. This division also manages the distribution of crucial specialized pharmaceutical products like plasma, blood derivatives, and vaccines. Beyond product supply, Cencora offers comprehensive support services, such as pharmacy management, staffing solutions, and strategic consulting. It develops and implements supply management software, provides packaging services for both institutional and retail healthcare settings, and assists with clinical trial support, post-market approval processes, and commercialization strategies. For biotechnology and pharmaceutical manufacturers, the company delivers data analytics, outcomes research, and other specialized services. Furthermore, Cencora serves the animal health market, providing pharmaceuticals, vaccines, parasiticides, diagnostics, and micro feed ingredients for both companion and production animals. It also offers sales force support to manufacturers and specialized services to medical professionals, particularly oncologists, as well as to hospitals and dialysis clinics. The International Healthcare Solutions division concentrates on global pharmaceutical wholesale activities, associated services, and worldwide commercialization support. It ensures the efficient distribution of medicines, various healthcare goods, and related services to an international customer base comprising pharmacies, doctors, health centers, and hospitals. This segment also delivers specialized transportation and logistics solutions specifically designed for the biopharmaceutical sector. Founded in 1871, the company was formerly known as AmerisourceBergen Corporation before adopting the name Cencora, Inc. in August 2023. Its corporate headquarters are situated in Conshohocken, Pennsylvania.
- Sector
- Healthcare
- Industry
- Medical - Distribution
- CEO
- Robert Mauch